Tuesday, 11 January 2022

Psychedelic Stock News: Awakn Life Sciences (OTCQB: AWKNF) Announces Positive Results from Phase II A/B Ketamine-Assisted Therapy for Treatment of Alcohol Use Disorder Trial

Psychedelic Stock News: Awakn Life Sciences (OTCQB: AWKNF) Announces Positive Results from Phase II A/B Ketamine-Assisted Therapy for Treatment of Alcohol Use Disorder Trial

No comments:

Post a Comment

Pot Stock Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) Continues Gains Ahead of Earnings

Pot Stock Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) Continues Gains Ahead of Earnings : Pot Stock Canopy Growth Corporation (TSX: ...